Firm

After genetic sequences and DNA, here comes RNA, the new flagship molecule in biotechnology that is supposed to solve agricultural and health problems. Companies in this field are flourishing. Among them is GreenLight Biosciences, a company that was on the verge of bankruptcy when it was bought by the investment fund Fall Line Capital.

In January 2024, two Danish industrial giants of the microorganisms merged and Novonesis was born. This company sells “biosolutions” for all industrial and agricultural areas. “Bio” for biotechnological… and not biological, as it prefers to emphasize. This company uses microorganisms, often genetically modified, to make them produce enzymes.

Toulouse-based Micropep Technologies has just had one of its fungicidal micropeptides approved in the United States. The technology, developed and patented by this CNRS spin-off, is aiming for European approval by 2030. However, these micropeptides are raising questions about their potential impact on ecosystems.